Cargando…
Cancer drug resistance: redox resetting renders a way
Disruption of redox homeostasis is a crucial factor in the development of drug resistance, which is a major problem facing current cancer treatment. Compared with normal cells, tumor cells generally exhibit higher levels of reactive oxygen species (ROS), which can promote tumor progression and devel...
Autores principales: | Liu, Yuan, Li, Qifu, Zhou, Li, Xie, Na, Nice, Edouard C., Zhang, Haiyuan, Huang, Canhua, Lei, Yunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173169/ https://www.ncbi.nlm.nih.gov/pubmed/27057637 http://dx.doi.org/10.18632/oncotarget.8600 |
Ejemplares similares
-
Redox Control of the Dormant Cancer Cell Life Cycle
por: Li, Bowen, et al.
Publicado: (2021) -
Redox signaling at the crossroads of human health and disease
por: Zuo, Jing, et al.
Publicado: (2022) -
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
por: Jin, Ping, et al.
Publicado: (2022) -
Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020) -
Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche
por: Shi, Jiayan, et al.
Publicado: (2022)